Dr. Ocean Discusses the Use of ctDNA in Pancreatic Cancer

Dr. Ocean on the Importance of Vitamin D Analogs in Pancreatic CancerПодробнее

Dr. Ocean on the Development of Nanoliposomal Irinotecan in Metastatic Pancreatic CancerПодробнее

ARTEMIS-PC: personalized panel for circulating tumor DNA in pancreatic cancerПодробнее

Dr. Allyson Ocean explains how and why social media empowers her work in #PancreaticCancerПодробнее

Dr. Ocean on Impact of the PRODIGE 24/CCTG PA.6 Trial in Pancreatic CancerПодробнее

Dr. Ocean on the Toxicities With SM-88 in Metastatic Pancreatic CancerПодробнее

Pancreatic Cancer - Dr. Allyson OceanПодробнее

ctDNA testing in pancreatic cancer and other upper GI malignanciesПодробнее

Dr. Picozzi on Prognostic Value of Pathologic Response to Chemo in Pancreatic CancerПодробнее

ctDNA measurement via liquid biopsy: improving cancer detection and diagnosisПодробнее

World Pancreatic Cancer Day brings attention to one of the deadliest cancersПодробнее

Current Status and perspectives on liquid biopsy in mCRCПодробнее

Potential Use of ctDNA and MRD in CRCПодробнее

Allyson Ocean, MD: Pancreas Cancer 101Подробнее

How can ctDNA be used as a biomarker for colon cancer?Подробнее

2021 West Oncology | Gastrointestinal Cancers | ctDNA Analysis in Colorectal CancerПодробнее

What Patients Need to Know About Circulating Tumor DNAПодробнее

PREVAIL: investigating ctDNA for the diagnosis of pancreatic and biliary duct cancerПодробнее

Advanced Pancreatic Cancer and Molecular TestingПодробнее